New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 14, 2013
15:26 EDTEXPR, DELL, GMCR, CELG, NYCBStocks with expanding option implied volatility; EXPR DELL GMCR CELG NYCB
News For EXPR;DELL;GMCR;CELG;NYCB From The Last 14 Days
Check below for free stories on EXPR;DELL;GMCR;CELG;NYCB the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
August 26, 2014
15:36 EDTEXPRNotable companies reporting before tomorrow's open
Subscribe for More Information
11:20 EDTCELGCelgene added to short term buy list at Deutsche Bank
Subscribe for More Information
09:35 EDTCELGActive equity options trading on open
Subscribe for More Information
07:00 EDTGMCRKeurig Kraft deal to provide market share boost, says William Blair
William Blair believes that Keurig Green Mountain's (GMCR) licensing deal with Kraft (KRFT) is an important step in Keurig's efforts to recapture unlicensed share. Following Keurig's decision to raise its portion pack prices by 9%, the firm thinks that the conversion of formerly unlicensed players likely enhances the ability of Keurig to implement price increases. William Blair keeps an Outperform rating on the stock.
August 25, 2014
12:19 EDTCELGOn The Fly: Midday Wrap
Subscribe for More Information
10:40 EDTCELGBiotechs rise after InterMune acquired by Roche
Subscribe for More Information
07:06 EDTGMCRKeurig Green Mountain reports release of Keurig 2.0 hot beverage brewing system
Subscribe for More Information
06:05 EDTGMCRStocks with implied volatility movement; GMCR TLM
Stocks with implied volatility movement; Keurig Green Mountain (GMCR) 34, Talisman Energy (TLM) 47 according to iVolatility.
August 22, 2014
16:20 EDTGMCROn The Fly: Closing Wrap
Subscribe for More Information
12:57 EDTGMCRKeurig Green Mountain surges after inking deal with Kraft
Subscribe for More Information
12:20 EDTGMCROn The Fly: Midday Wrap
Subscribe for More Information
10:43 EDTGMCRKeurig Green Mountain volatility low, shares up on Kraft licensing agreement
Subscribe for More Information
09:01 EDTGMCRKeurig Green Mountain, Kraft Foods announce licensing agreement
Subscribe for More Information
August 20, 2014
08:02 EDTCELGBristol-Myers, Celgene enter collaboration agreement for OPDIVO, ABRAXANE
Subscribe for More Information
August 19, 2014
09:38 EDTCELGActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL GILD TSLA CELG VLO VZ FB HD
09:01 EDTGMCRKeurig Green Mountain estimates raised at SunTrust
Subscribe for More Information
07:33 EDTCELGCelgene announces publication of REVLIMID combination results
Celgene announced that results of a study evaluating the combination of REVLIMID with rituximab, cyclophosphamide, doxorubicin hydrochloride, vincristine sulfate and prednisone in untreated diffuse large b-cell lymphoma were published online ahead of print in the Journal of Clinical Oncology. In a phase II, open label, single arm study, 64 patients with newly diagnosed, untreated, stage II-IV CD20 positive DLBCL received 25 mg of lenalidomide on days 1-10 with standard dose R-CHOP every 21 days for six cycles. All patients received pegfilgrastim on day two of each cycle and aspirin prophylaxis throughout. The primary endpoint was event-free survival with secondary endpoints of progression free survival and overall survival. A one-stage binomial design was used to assess the efficacy and tolerability of REVLIMID with R-CHOP. Of the 64 patients enrolled, 60 were eligible for response evaluation. In these patients, the overall response rate was 98% with 80% achieving a complete response. The 24-month EFS, which was identical to PFS, and OS rates were 59% and 78%, respectively. The company said, "This study demonstrated that the addition of lenalidomide to conventional R-CHOP resulted in similar PFS rates and OS rates between sub-types. This is intriguing as patients with the non-GCB phenotype have traditionally experienced poorer outcomes. The results of this study support further evaluation of this regimen in this sub-type of DLBCL.
August 15, 2014
12:16 EDTGMCRMonster surges as Coca-Cola takes 16.7% stake in company
Subscribe for More Information
August 14, 2014
07:39 EDTGMCRKeurig Green Mountain estimates lowered well below consensus at SunTrust
SunTrust lowered forecasts well below consensus for Keurig Green Mountain, as the firm believes its gross margins will be impacted by higher green coffee costs and new product launches. The firm's FY15 EPS estimate goes to $3.70 from $4.00, vs. consensus of $4.05, and FY16 was lowered to $4.39 from $4.49. When the company reports Q4 result in November, the analyst expects the company to provide FY15 guidance around its new estimate and for Street estimates to move lower. Shares are Neutral rated with a lowered price target of $110, down from $115.
07:07 EDTGMCRKeurig Green Mountain announces price increase, effective November 3
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use